ORTHOPEDIATRICS CORP
About ORTHOPEDIATRICS CORP
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $236.3M
- Net income
- -$39.6M
- Total assets
- $508.6M
- Market cap
- $470.5M
- Gross margin
- 73.1%
- Operating margin
- -16.6%
- Net margin
- -16.8%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $236.3M
- Cost of revenue
- $63.7M
- Gross profit
- $172.7M
- Operating expenses
- $211.9M
- Operating income
- -$39.2M
- Income tax
- $460.0K
- Net income
- -$39.6M
- EPS (basic)
- $-1.69
- EPS (diluted)
- $-1.69
Balance sheet
- Total assets
- $508.6M
- Current assets
- $256.4M
- Total liabilities
- $162.0M
- Current liabilities
- $46.2M
- Shareholders’ equity
- $346.6M
Cash flow
- Operating cash flow
- -$4.9M
- Investing cash flow
- -$43.6M
- Financing cash flow
- $24.0M
- Net cash flow
- -$24.2M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $470.5M
- EPS (diluted)
- $-1.69
- Shares outstanding
- 25.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 12, 2017
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $39.6M in FY2025.
- Revenue grew 141% from FY2021 to FY2025.
- Gross margin of 73.1%, net margin -16.8%.
- Trading 23% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ORTHOPEDIATRICS CORP.
Write a review
News about ORTHOPEDIATRICS CORP
News & sentiment via Polygon.io
